{"id":43355,"date":"2024-07-24T05:14:47","date_gmt":"2024-07-24T05:14:47","guid":{"rendered":"https:\/\/www.nsemgh.com\/?p=43355"},"modified":"2024-07-24T05:14:49","modified_gmt":"2024-07-24T05:14:49","slug":"president-of-kobayashi-pharmaceutical-to-resign-after-report-of-drug-linked-to-80-deaths","status":"publish","type":"post","link":"https:\/\/www.nsemgh.com\/2024\/07\/24\/president-of-kobayashi-pharmaceutical-to-resign-after-report-of-drug-linked-to-80-deaths\/","title":{"rendered":"President of Kobayashi Pharmaceutical to resign after report of drug linked to 80 deaths"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The chairman and president of a major Japanese dietary supplement maker is to resign, as the company probes up to 80 deaths potentially linked to dietary supplements meant to lower cholesterol.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Kobayashi Pharmaceutical, a household name in Japan, is at the centre of heath fears linked to its over-the-counter tablets containing red yeast rice, which is fermented with a mould culture.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The company\u2019s board released a damning\u00a0external report\u00a0on Tuesday that said the firm had failed to prioritise consumer safety and acted with an \u201cinsufficient sense of urgency\u201d. The report by a team of external lawyers said the company began to receive reports of kidney problems from doctors in mid-January and early February.<\/p>\n\n\n\n<figure class=\"wp-block-image\" id=\"2f388ee9-a290-4bdc-8c18-7509f36ee495\"><a href=\"https:\/\/www.theguardian.com\/world\/2024\/mar\/27\/japan-dietary-supplement-recall-beni-koji-red-yeast-rice-cholesterol-kobayashi-pharmaceutical-investigation-kidney-disease\"><img decoding=\"async\" src=\"https:\/\/i.guim.co.uk\/img\/media\/a46e54a169ad93d721217c612268c679a7d27aa1\/35_0_567_340\/master\/567.jpg?width=460&amp;quality=85&amp;auto=format&amp;fit=max&amp;s=1f05c1e51954bbcc09e178ed11283306\" alt=\"Dietary supplements recalled on 22 March 2024 by Japanese drugmaker Kobayashi Pharmaceutical. The products contain an ingredient called red yeast rice, or \u201cbeni koji\u201d, which the company says may be linked to kidney problems and at least one death.\"\/><\/a><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Red yeast rice or\u00a0\u201cbeni koji\u201dhas been used in food, alcoholic drinks and folk medicine for centuries around east Asia.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Medical studies say it can improve cholesterol levels but also warn of a risk of organ damage depending on the ingredient\u2019s chemical makeup.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Kobayashi Pharmaceutical said president Akihiro Kobayashi and chairman Kazumasa Kobayashi were leaving their posts. Both men belong to the firm\u2019s founding family.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The decision was made \u201cto clarify executive responsibility over a series of actions by our company related to the \u2018beni koji\u2019 issue\u201d, it said in a statement.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The scandal erupted in March when the company recalled three brands of dietary supplements after customers complained of kidney problems.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It later said it had detected a potentially toxic acid produced by the mould at one of its factories, and the government inspected the firm\u2019s facilities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Then last month, the\u00a0company said it was probing a total of 80 deaths\u00a0possibly connected to its pills, and investigating whether organs other than kidneys were harmed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">At the time, the government called Kobayashi Pharmaceutical\u2019s delay in reporting the number of cases under investigation \u201cextremely regrettable\u201d.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The lawyers said in Tuesday\u2019s report: \u201cKobayashi Pharmaceutical had never before received multiple reports of serious cases from doctors in such a short period of time.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cDespite this, the company did not immediately consider disclosure to consumers, acting with an insufficient sense of urgency.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The company should have recalled the products right away and reported the incident, but it decided to do so only after conducting internal probes, the lawyers alleged.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Kobayashi Pharmaceutical\u2019s new president is Satoshi Yamane, previously head of sustainability policy, the company said.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Outgoing president Akihiro Kobayashi, who has expressed his intention to take responsibility for any harm caused, will remain in an executive role to manage compensation-related matters, it added.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The chairman and president of a major Japanese dietary supplement maker is to resign, as the company probes up to 80 deaths potentially linked to dietary supplements meant to lower cholesterol. Kobayashi Pharmaceutical, a household name in Japan, is at the centre of heath fears linked to its over-the-counter tablets containing red yeast rice, which [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":43356,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_post_source_name":"","_post_source_url":"","footnotes":""},"categories":[64,54],"tags":[5274,7489,8051,3513,7234,539,5257,11273,5455,9127,6496,2264,10197,2959,9326,11382,10303,12309,6527,11081,3805,8297,8045,5807,12264,594],"class_list":["post-43355","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-fitness","category-obituary","tag-asia","tag-chairman","tag-consumers","tag-culture","tag-death","tag-delay","tag-doctors","tag-drug","tag-family","tag-february","tag-food","tag-government","tag-investigation","tag-japan","tag-japanese","tag-kobayashi-pharmaceuticals","tag-medicine","tag-men","tag-organs","tag-pharmaceutical","tag-president","tag-resign","tag-rice","tag-risk","tag-scandal","tag-who"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/www.nsemgh.com\/api-json\/wp\/v2\/posts\/43355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nsemgh.com\/api-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nsemgh.com\/api-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nsemgh.com\/api-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nsemgh.com\/api-json\/wp\/v2\/comments?post=43355"}],"version-history":[{"count":1,"href":"https:\/\/www.nsemgh.com\/api-json\/wp\/v2\/posts\/43355\/revisions"}],"predecessor-version":[{"id":43357,"href":"https:\/\/www.nsemgh.com\/api-json\/wp\/v2\/posts\/43355\/revisions\/43357"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nsemgh.com\/api-json\/wp\/v2\/media\/43356"}],"wp:attachment":[{"href":"https:\/\/www.nsemgh.com\/api-json\/wp\/v2\/media?parent=43355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nsemgh.com\/api-json\/wp\/v2\/categories?post=43355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nsemgh.com\/api-json\/wp\/v2\/tags?post=43355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}